"With all the advances, Heck said, breast cancer is coming into its own as a specialty. When he attends national breast cancer conferences, “everyone is so excited about what’s going on in the field. We’re learning more and more about the genetics of cancer.”
Most importantly, advances are occurring in early detection, “which is everything in breast cancer treatment,” Heck said."
I do not agree. If Brevagen is selling, it will not take long for revenue or at least projected revenue to impact GENE. Phenogen Sciences sales force is working very hard in getting the word out to physicians. If they came out and gave some indication of how it is going we could rock.